Sanofi Share Price Borsa Italiana

Equities

1SAN

FR0000120578

Pharmaceuticals

Real-time Estimate Tradegate 04:45:48 27/06/2024 pm IST 5-day change 1st Jan Change
90.36 EUR +2.59% Intraday chart for Sanofi +1.15% -1.59%

Financials

Sales 2024 * 4.64TCr 4.96TCr 4,13800Cr Sales 2025 * 4.99TCr 5.34TCr 4,45700Cr Capitalization 11TCr 12TCr 10,13200Cr
Net income 2024 * 708.2Cr 758.01Cr 63TCr Net income 2025 * 869.1Cr 930.23Cr 78TCr EV / Sales 2024 * 2.6 x
Net Debt 2024 * 699.18Cr 748.36Cr 62TCr Net Debt 2025 * 236.85Cr 253.52Cr 21TCr EV / Sales 2025 * 2.32 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
13.1 x
Employees 86,088
Yield 2024 *
4.26%
Yield 2025 *
4.48%
Free-Float 87.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.57%
1 week+1.15%
Current month-1.78%
1 month-1.78%
3 months-3.69%
6 months-1.54%
Current year-1.59%
More quotes
1 week
86.81
Extreme 86.81000000
92.25
1 month
86.20
Extreme 86.2
92.25
Current year
84.98
Extreme 84.98
98.49
1 year
80.75
Extreme 80.75
104.22
3 years
76.36
Extreme 76.36
106.06
5 years
68.00
Extreme 68
106.06
10 years
63.15
Extreme 63.15
106.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/19/01
Chief Operating Officer 40 01/22/01
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 01/14/01
Director/Board Member 62 28/20/28
Director/Board Member 64 22/20/22
More insiders
Date Price Change Volume
20/24/20 88.07 +1.15% 557
26/24/26 91.7 +0.71% 2,006
25/24/25 91.05 +0.47% 182
24/24/24 90.62 +4.15% 1,684
21/24/21 87.01 -1.20% 458

End-of-day quote Borsa Italiana, June 20, 2024

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.79 EUR
Average target price
108.2 EUR
Spread / Average Target
+19.17%
Consensus